Ahmet Zehir

2009–2025 年に発表

150
論文数
44,919
被引用数
82
h 指数
143
i10 指数

被引用数

Ahmet Zehir の年別被引用数1976 年: 被引用 2 件1977 年: 被引用 2 件1992 年: 被引用 2 件1998 年: 被引用 2 件2000 年: 被引用 1 件2004 年: 被引用 3 件2007 年: 被引用 2 件2009 年: 被引用 2 件2010 年: 被引用 7 件2011 年: 被引用 6 件2012 年: 被引用 6 件2013 年: 被引用 7 件2014 年: 被引用 4 件2015 年: 被引用 24 件2016 年: 被引用 75 件2017 年: 被引用 175 件2018 年: 被引用 533 件2019 年: 被引用 2,028 件2020 年: 被引用 3,064 件2021 年: 被引用 3,362 件2022 年: 被引用 2,954 件2023 年: 被引用 2,195 件2024 年: 被引用 3,192 件2025 年: 被引用 1,455 件2026 年: 被引用 55 件1978〜1991 年は被引用が無いため表示していません1993〜1997 年は被引用が無いため表示していません1999 年は被引用が無いため表示していません2001〜2003 年は被引用が無いため表示していません2005〜2006 年は被引用が無いため表示していません2008 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 6,948 件、この内訳の 28.9%中国: 引用元論文 2,825 件、この内訳の 11.8%イギリス: 引用元論文 1,359 件、この内訳の 5.7%イタリア: 引用元論文 1,255 件、この内訳の 5.2%ドイツ: 引用元論文 1,203 件、この内訳の 5%フランス: 引用元論文 905 件、この内訳の 3.8%カナダ: 引用元論文 865 件、この内訳の 3.6%スペイン: 引用元論文 842 件、この内訳の 3.5%日本: 引用元論文 827 件、この内訳の 3.4%オーストラリア: 引用元論文 655 件、この内訳の 2.7%オランダ: 引用元論文 608 件、この内訳の 2.5%スイス: 引用元論文 536 件、この内訳の 2.2%
0%28.9%その他 21.7%

分野

  • Medicine64%
  • Biochemistry, Genetics and Molecular Biology30.2%
  • Immunology and Microbiology3.2%
  • Computer Science1%
  • Agricultural and Biological Sciences0.3%
  • Engineering0.3%
  • その他1%

トピック

  • Cancer Genomics and Diagnostics8.7%
  • Cancer Immunotherapy and Biomarkers7%
  • Lung Cancer Treatments and Mutations4.2%
  • Genetic factors in colorectal cancer3%
  • Ferroptosis and cancer prognosis2.2%
  • Immunotherapy and Immune Responses2.1%
  • その他72.8%

共著者

全論文

検索で開く
  1. Tumor mutational load predicts survival after immunotherapy across multiple cancer types

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philip H. Gutin, Cameron Brennan, Viviane Tabar, Ingo K. Mellinghoff, Lisa M. DeAngelis, Charlotte E. Ariyan, Nancy Y. Lee, William D. Tap, Mrinal M. Gounder, Sandra P. D’Angelo, Leonard B. Saltz, Zsofia K. Stadler, Howard I. Scher, José Baselga, Pedram Razavi, Christopher A. Klebanoff, Rona Yaeger, Neil H. Segal, Geoffrey Y. Ku, Ronald P. DeMatteo, Marc Ladanyi, Naiyer A. Rizvi, Michael F. Berger, Nadeem Riaz, David B. Solit, Timothy A. Chan, Luc G.T. Morris - Nature Genetics 2019 被引用: 4,358

  2. OncoKB: A Precision Oncology Knowledge Base

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonio Omuro, Michael A. Postow, Dana E. Rathkopf, Alexander N. Shoushtari, Neerav Shukla, Martin H. Voss, Ederlinda Paraiso, Ahmet Zehir, Michael F. Berger, Barry S. Taylor, Leonard B. Saltz, Gregory J. Riely, Marc Ladanyi, David M. Hyman, José Baselga, Paul Sabbatini, David B. Solit, Nikolaus Schultz - JCO Precision Oncology 2017 被引用: 2,698

  3. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laetitia Borsu, Justyna Sadowska, Jacklyn Casanova, Ruben Bacares, Iwona Kiecka, Anna Razumova, Julie B Son, Lisa Stewart, Tessara Baldi, Kerry Mullaney, Hikmat Al‐Ahmadie, Efsevia Vakiani, Adam Abeshouse, Alexander Penson, Philip Jonsson, Niedzica Camacho, Matthew T. Chang, Helen Won, Benjamin Groß, Ritika Kundra, Zachary Heins, Hsiao‐Wei Chen, Sarah Phillips, Hongxin Zhang, Jiaojiao Wang, Angelica Ochoa, Jonathan Wills, Michael Eubank, Stacy B. Thomas, Stuart M. Gardos, Dalicia N. Reales, Jesse Galle, Robert Durany, Roy Cambria, Wassim Abida, Andrea Cercek, Darren R. Feldman, Mrinal M. Gounder, A. Ari Hakimi, James J. Harding, Gopa Iyer, Yelena Y. Janjigian, Emmet Jordan, Ciara M. Kelly, Maeve A. Lowery, Luc G.T. Morris, Antonio Omuro, Nitya Raj, Pedram Razavi, Alexander N. Shoushtari, Neerav Shukla, Tara E. Soumerai, Anna M. Varghese, Rona Yaeger, Jonathan Coleman, Bernard H. Bochner, Gregory J. Riely, Leonard B. Saltz, Howard I. Scher, Paul Sabbatini, Mark E. Robson, David S. Klimstra, Barry S. Taylor, José Baselga, Nikolaus Schultz, David M. Hyman, Maria E. Arcila, David B. Solit, Marc Ladanyi, Michael F. Berger - Nature Medicine 2017 被引用: 3,517

  4. AACR Project GENIE: Powering Precision Medicine through an International Consortium

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Walter Kinyua, Priti Kumari, Ritika Kundra, Marc Ladanyi, Céline Lefèbvre, Michele L. Lenoue-Newton, Eva M. Lepisto, Mia Levy, Neal I. Lindeman, James Lindsay, David Liu, Zhibin Lu, Laura E. MacConaill, Ian Maurer, David S. Maxwell, Gerrit A. Meijer, Funda Meric‐Bernstam, Christine Micheel, Clinton Miller, Gordon B. Mills, Nathanael D. Moore, Petra M. Nederlof, Larsson Omberg, John A. Orechia, Ben Ho Park, Trevor J. Pugh, Brendan Reardon, Barrett J. Rollins, Mark J. Routbort, Charles L. Sawyers, Deborah Schrag, Nikolaus Schultz, Kenna Shaw, Priyanka Shivdasani, Lillian L. Siu, David B. Solit, Gabe S. Sonke, Jean Charles Soria, Parin Sripakdeevong, Natalie Stickle, Thomas Stricker, Shawn M. Sweeney, Barry S. Taylor, Jelle J. ten Hoeve, Stacy B. Thomas, Eliezer M. Van Allen, Laura van ‘t Veer, Tony van de Velde, Harm van Tinteren, Victor E. Velculescu, Carl Virtanen, Emile E. Voest, Lucy Lu Wang, Chetna Wathoo, Stuart Watt, Celeste Yu, Thomas Yu, Emily Yu, Ahmet Zehir, Hongxin Zhang - Cancer Discovery 2017 被引用: 2,004

  5. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Molecular Diagnostics 2015 被引用: 2,155

  6. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yelena Y. Janjigian, Michael J. Morris, Robert J. Motzer, Eileen M. O’Reilly, Michael A. Postow, Nitya Raj, Gregory J. Riely, Mark E. Robson, Jonathan E. Rosenberg, Anton Safonov, Alexander N. Shoushtari, William D. Tap, Min Yuen Teo, Anna M. Varghese, Martin H. Voss, Rona Yaeger, Marjorie G. Zauderer, Nadeem R. Abu‐Rustum, Julio García‐Aguilar, Bernard H. Bochner, A. Ari Hakimi, William R. Jarnagin, David R. Jones, Daniela Molena, Luc G.T. Morris, Eric Rios‐Doria, Paul Russo, Samuel Singer, Vivian E. Strong, Debyani Chakravarty, Lora H. Ellenson, Anuradha Gopalan, Jorge S. Reis‐Filho, Britta Weigelt, Marc Ladanyi, Mithat Gönen, Sohrab P. Shah, Joan Massagué, Jianjiong Gao, Ahmet Zehir, Michael F. Berger, David B. Solit, Samuel F. Bakhoum, Francisco Sánchez-Vega, Nikolaus Schultz - Cell 2022 被引用: 663

  7. Cancer therapy shapes the fitness landscape of clonal hematopoiesis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Konrad H. Stopsack, Barbara Spitzer, Simon Mantha, James A. Fagin, Laura Boucai, Christopher J. Gibson, Benjamin L. Ebert, Andrew L. Young, Todd E. Druley, Koichi Takahashi, Nancy Gillis, Markus Ball, Eric Padron, David M. Hyman, José Baselga, Larry Norton, Stuart M. Gardos, Virginia M. Klimek, Howard I. Scher, Dean F. Bajorin, Eder Paraiso, Ryma Benayed, Maria E. Arcila, Marc Ladanyi, David B. Solit, Michael F. Berger, Martin S. Tallman, Montserrat García‐Closas, Nilanjan Chatterjee, Luis A. Díaz, Ross L. Levine, Lindsay M. Morton, Ahmet Zehir, Elli Papaemmanuil - Nature Genetics 2020 被引用: 741

  8. The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nikolaus Schultz, Mark E. Robson, Clifford A. Hudis, Edi Brogi, Agnès Viale, Larry Norton, Maura N. Dickler, Michael F. Berger, Christine A. Iacobuzio–Donahue, Sarat Chandarlapaty, Maurizio Scaltriti, Jorge S. Reis‐Filho, David B. Solit, Barry S. Taylor, José Baselga - Cancer Cell 2018 被引用: 1,006

  9. Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes

    著者: , , , , , , , , , , , , , , - Cell stem cell 2017 被引用: 855

  10. Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Liying Zhang, Ahmet Zehir, Joseph Vijai, Howard I. Scher, Charles L. Sawyers, Nikolaus Schultz, Philip W. Kantoff, David B. Solit, Mark E. Robson, Eliezer M. Van Allen, Kenneth Offit, Johann S. de Bono, Peter S. Nelson - New England Journal of Medicine 2016 被引用: 1,663

  11. Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nikolaus Schultz, Matthew D. Hellmann - Journal of Clinical Oncology 2018 被引用: 1,421

  12. Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2023 被引用: 391

  13. Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy

    著者: , , , , , , , , , , , , , , , , , , , - Science 2017 被引用: 1,185

  14. Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2018 被引用: 864

  15. Variant Review with the Integrative Genomics Viewer

    著者: , , , , - Cancer Research 2017 被引用: 1,251

  16. Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Howard I. Scher - JAMA Oncology 2018 被引用: 663

  17. Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2021 被引用: 456

  18. Improved prediction of immune checkpoint blockade efficacy across multiple cancer types

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mithat Gönen, Luc G.T. Morris, Nils Weinhold, Timothy A. Chan - Nature Biotechnology 2021 被引用: 270

  19. Genome doubling shapes the evolution and prognosis of advanced cancers

    著者: , , , , , , , , , , , , , , , , , , , - Nature Genetics 2018 被引用: 692

  20. Single-cell mutation analysis of clonal evolution in myeloid malignancies

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Nature 2020 被引用: 529

  21. Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Albrecht Stenzinger, Mark Stewart, Jeff Allen - Journal for ImmunoTherapy of Cancer 2020 被引用: 506

  22. Genetic diversity of tumors with mismatch repair deficiency influences anti–PD-1 immunotherapy response

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Science 2019 被引用: 581

  23. Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention

    著者: , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2018 被引用: 578

  24. Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barry S. Taylor, Marc Ladanyi, Diana Mandelker, Liying Zhang, Victor E. Reuter, Philip W. Kantoff, David B. Solit, Michael F. Berger, Charles L. Sawyers, Nikolaus Schultz, Howard I. Scher - JCO Precision Oncology 2017 被引用: 531